Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergocalciferol in Calcidiol Deficient Hemodialysis Patients
NCT02011828Phase 1Completed
- Sponsor
- University of Utah
- Start
- May 2009
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD), inflammation and insulin resistance (IR) (2 arms), sponsored by University of Utah. Primary endpoint: Interleukin-6 at 28 weeks. Started May 2009; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)inflammationinsulin resistance (IR)
Beyond the preview
Go deeper on NCT02011828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011828.